NFKB1 and liver cancer: To further verify that APKO promotes DEN-induced hepatocarcinogenesis by activating the NF-κB pathway, QNZ (an inhibitor of the NF-κB pathway) was injected intraperitoneally in the process of DEN-induced liver cancer formation in mice.